HBV vaccination coverage among health-care workers De Schryver et al. were rightly concerned by the HBV vaccination coverage among health-care workers (HCWs) in 11 countries of the European Union where it is mandatory. France is among those where no data are available and some information about a very specific situation must be disclosed. On 3 November 2010, the members of parliament voted a E1...

BACKGROUND Hepatitis B infection is a global public health problem affecting various sectors in the society. Vaccination is the first line measure to prevent the disease. OBJECTIVES To assess the persistence of anti-HBs marker among medical students after 18 - 22 of vaccination as an indicator for Hepatitis B virus vaccine efficacy. PATIENTS AND METHODS In this study, 249 Palestinian medica...

HBV vaccination coverage among health-care workers De Schryver et al. were rightly concerned by the HBV vaccination coverage among health-care workers (HCWs) in 11 countries of the European Union where it is mandatory. France is among those where no data are available and some information about a very specific situation must be disclosed. On 3 November 2010, the members of parliament voted a E1...

BACKGROUND Despite the introduction of universal hepatitis B immunization programs worldwide, outbreaks of acute infection still occur in unimmunized individuals. A timely diagnosis of hepatitis B is necessary to ensure adequate clinical care and public health interventions that will reduce transmission. Yet, interpretation of hepatitis B serological markers can be complex. We present a case of...

The immune system becomes less effective with age, and older age is associated with an increased susceptibility to diseases and reduced responses to vaccination. Furthermore, some adult populations, such as those with diabetes mellitus, are at increased risk of acute hepatitis B virus (HBV) infection. Decreasing responses to vaccination with advanced age have been described, but it is not known...

The case history is presented of a previously healthy non-atopic woman who developed cutaneous vasculitis, confirmed by biopsy, and pulmonary problems after inoculatiorn with recombinant hepatitis B vaccine. (Thorax 1993;48:580-581) Vaccination with hepatitis B recombinant vaccine is highly effective in producing immunity in immunocompetent patients. It has few side effects, usually consisting ...

BACKGROUND In 2000, hexavac and infanrix hexa were licensed in Europe for primary immunisation of children against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive infections caused by Haemophilus influenzae b. In 2005, hexavac was suspended because of concerns about the long-term immunogenicity of its hepatitis B component. We aimed to assess the duration of immunity an...

OBJECTIVES To determine the pattern of vaccine uptake by hospital personnel in a specifically designed pioneer hepatitis B vaccination programme and to highlight major lessons for ensuring success in future programmes. DESIGN A review of vaccination and employment records for a forty four-month period and comparative analysis on the basis of professional grouping and work units. SETTING Oba...